- Home
- GDHG vs PMN Comparison
GDHG vs PMN Comparison
Compare GDHG & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDHG
- PMN
- Stock Information
- Founded
- GDHG 2008
- PMN 2004
- Country
- GDHG China
- PMN Canada
- Employees
- GDHG N/A
- PMN N/A
- Industry
- GDHG Services-Misc. Amusement & Recreation
- PMN Pharmaceuticals and Biotechnology
- Sector
- GDHG Consumer Discretionary
- PMN Health Care
- Exchange
- GDHG Nasdaq
- PMN Nasdaq
- Market Cap
- GDHG 19.4M
- PMN 16.0M
- IPO Year
- GDHG 2023
- PMN N/A
- Fundamental
- Price
- GDHG $0.43
- PMN $0.63
- Analyst Decision
- GDHG
- PMN Strong Buy
- Analyst Count
- GDHG 0
- PMN 3
- Target Price
- GDHG N/A
- PMN $4.33
- AVG Volume (30 Days)
- GDHG 1.3M
- PMN 16.6M
- Earning Date
- GDHG 08-19-2025
- PMN 08-19-2025
- Dividend Yield
- GDHG N/A
- PMN N/A
- EPS Growth
- GDHG N/A
- PMN N/A
- EPS
- GDHG N/A
- PMN N/A
- Revenue
- GDHG $16,666,899.00
- PMN N/A
- Revenue This Year
- GDHG N/A
- PMN N/A
- Revenue Next Year
- GDHG N/A
- PMN N/A
- P/E Ratio
- GDHG N/A
- PMN N/A
- Revenue Growth
- GDHG N/A
- PMN N/A
- 52 Week Low
- GDHG $0.16
- PMN $0.38
- 52 Week High
- GDHG $174.63
- PMN $1.59
- Technical
- Relative Strength Index (RSI)
- GDHG 30.86
- PMN 48.45
- Support Level
- GDHG $0.16
- PMN $0.77
- Resistance Level
- GDHG $0.72
- PMN $1.06
- Average True Range (ATR)
- GDHG 0.16
- PMN 0.11
- MACD
- GDHG 0.06
- PMN -0.04
- Stochastic Oscillator
- GDHG 48.61
- PMN 16.92
About GDHG Golden Heaven Group Holdings Ltd.
Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, It manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The parks collectively contain nearly 159 rides and attractions. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.